1452 related articles for article (PubMed ID: 33907095)
1. Wild type transthyretin cardiac amyloidosis in a young individual: A case report.
Ghosh S; Khanra D; Krishna V; Thakur AK
Medicine (Baltimore); 2021 Apr; 100(17):e25462. PubMed ID: 33907095
[TBL] [Abstract][Full Text] [Related]
2. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
[TBL] [Abstract][Full Text] [Related]
3. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.
Arvanitis M; Koch CM; Chan GG; Torres-Arancivia C; LaValley MP; Jacobson DR; Berk JL; Connors LH; Ruberg FL
JAMA Cardiol; 2017 Mar; 2(3):305-313. PubMed ID: 28196196
[TBL] [Abstract][Full Text] [Related]
4. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
[TBL] [Abstract][Full Text] [Related]
5. First Norwegian case of hereditary ATTR amyloidosis with a novel transthyretin variant.
Lyng CS; Gude E; Hodt A; Knudsen EC
Scand Cardiovasc J; 2023 Dec; 57(1):2174269. PubMed ID: 36734834
[TBL] [Abstract][Full Text] [Related]
6. Disease-Specific Biomarkers in Transthyretin Cardiac Amyloidosis.
Hendren NS; Roth LR; Grodin JL
Curr Heart Fail Rep; 2020 Jun; 17(3):77-83. PubMed ID: 32356182
[TBL] [Abstract][Full Text] [Related]
7. Pitfalls for the non-invasive diagnosis of wild-type transthyretin amyloid cardiomyopathy in a young adult: a case report.
Chang HC; Kuo L; Chung FP; Yu WC
Eur Heart J Case Rep; 2023 Jul; 7(7):ytad308. PubMed ID: 37501713
[TBL] [Abstract][Full Text] [Related]
8. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis.
Ihse E; Ybo A; Suhr O; Lindqvist P; Backman C; Westermark P
J Pathol; 2008 Oct; 216(2):253-61. PubMed ID: 18729067
[TBL] [Abstract][Full Text] [Related]
9. Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).
Maurer MS; Hanna M; Grogan M; Dispenzieri A; Witteles R; Drachman B; Judge DP; Lenihan DJ; Gottlieb SS; Shah SJ; Steidley DE; Ventura H; Murali S; Silver MA; Jacoby D; Fedson S; Hummel SL; Kristen AV; Damy T; Planté-Bordeneuve V; Coelho T; Mundayat R; Suhr OB; Waddington Cruz M; Rapezzi C;
J Am Coll Cardiol; 2016 Jul; 68(2):161-72. PubMed ID: 27386769
[TBL] [Abstract][Full Text] [Related]
10. Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden.
Lauppe RE; Liseth Hansen J; Gerdesköld C; Rozenbaum MH; Strand AM; Vakevainen M; Kuusisto J; Gude E; Gustafsson F; Smith JG
Open Heart; 2021 Oct; 8(2):. PubMed ID: 34645699
[TBL] [Abstract][Full Text] [Related]
11.
Tahara N; Lairez O; Endo J; Okada A; Ueda M; Ishii T; Kitano Y; Lee HE; Russo E; Kubo T
ESC Heart Fail; 2022 Feb; 9(1):251-262. PubMed ID: 34841715
[TBL] [Abstract][Full Text] [Related]
12. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met.
Tsuchiya-Suzuki A; Yazaki M; Kametani F; Sekijima Y; Ikeda S
Hum Pathol; 2011 Feb; 42(2):236-43. PubMed ID: 21056899
[TBL] [Abstract][Full Text] [Related]
13. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
Paton DM
Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study.
Ueda M; Horibata Y; Shono M; Misumi Y; Oshima T; Su Y; Tasaki M; Shinriki S; Kawahara S; Jono H; Obayashi K; Ogawa H; Ando Y
Mod Pathol; 2011 Dec; 24(12):1533-44. PubMed ID: 21822203
[TBL] [Abstract][Full Text] [Related]
15. Abdominal fat pad biopsies exhibit good diagnostic accuracy in patients with suspected transthyretin amyloidosis.
Paulsson Rokke H; Sadat Gousheh N; Westermark P; Suhr OB; Anan I; Ihse E; Pilebro B; Wixner J
Orphanet J Rare Dis; 2020 Oct; 15(1):278. PubMed ID: 33032630
[TBL] [Abstract][Full Text] [Related]
16. Wild-type Transthyretin Amyloidosis with Diffuse Alveolar-septal Amyloidosis Diagnosed by a Transbronchial Lung Biopsy.
Ishida M; Enomoto M; Hata T; Tanaka T; Sakaguchi C; Tamiya N; Tsuchiya M; Nagasaka Y
Intern Med; 2022; 61(14):2203-2207. PubMed ID: 35850989
[TBL] [Abstract][Full Text] [Related]
17. Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis.
Hirakawa K; Takashio S; Marume K; Yamamoto M; Hanatani S; Yamamoto E; Sakamoto K; Izumiya Y; Kaikita K; Oda S; Utsunomiya D; Shiraishi S; Ueda M; Yamashita T; Yamashita Y; Ando Y; Tsujita K
ESC Heart Fail; 2019 Feb; 6(1):122-130. PubMed ID: 30284755
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis.
Lioncino M; Monda E; Palmiero G; Caiazza M; Vetrano E; Rubino M; Esposito A; Salerno G; Dongiglio F; D'Onofrio B; Verrillo F; Cerciello G; Manganelli F; Pacileo G; Bossone E; Golino P; Calabrò P; Limongelli G
Heart Fail Clin; 2022 Jan; 18(1):73-87. PubMed ID: 34776085
[TBL] [Abstract][Full Text] [Related]
19. [Transthyretin amyloid cardiomyopathy. Features of histological diagnosis: study design].
Guselnikova VV; Fedorova EA; Gudkova AJ; Shavlovsky MM; Korzhevskii DE
Ter Arkh; 2022 May; 94(4):473-478. PubMed ID: 36286795
[TBL] [Abstract][Full Text] [Related]
20. Yield of noncardiac biopsy for the diagnosis of transthyretin cardiac amyloidosis.
Fine NM; Arruda-Olson AM; Dispenzieri A; Zeldenrust SR; Gertz MA; Kyle RA; Swiecicki PL; Scott CG; Grogan M
Am J Cardiol; 2014 May; 113(10):1723-7. PubMed ID: 24698461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
